A. Andrzejewska et G. Jurkowska, Nitric oxide protects the ultrastructure of pancreatic acinar cells in thecourse of caerulein-induced acute pancreatitis, INT J EXP P, 80(6), 1999, pp. 317-324
Nitric oxide (NO) as a unique biologicalmediator that has been implicated i
n many physiological and pathophysiological processes may have a significan
t influence on the course of acute pancreatitis and the recovery process. T
he aim of the study was to evaluate the effect of a NO synthase inhibitor o
r a substrate for NO endogenous production on the ultrastructural features
of the acinar cells in the course of caerulein-induced acute pancreatitis.
Acute pancreatitis was induced in the rats by a supramaximal dose of caerul
ein, During acute pancreatitis induction, the rats were treated with L-argi
nine (the substrate for NO synthesis), N-G-nitro-L-arginine (L-NNA, NO synt
hase inhibitor), L-arginine + L-NNA or saline. Light and electron microscop
y examinations were performed in all groups after pancreatitis induction an
d additionally after 7 and 14 days of recovery. The study demonstrated that
the NO synthase inhibitor given during pancreatitis induction in rats enha
nces the damage to the acinar cells, detected ultrastructurally, and increa
ses the cellular inflammatory infiltration. In the later period, the consid
erable damage to the mitochondria and the changes in secretory compartment
were observed, including dilated cisternae of Golgi apparatus, focal degran
ulation of rough endoplasmic reticulum, and reduced number of zymogen granu
les and condensing vacuoles. L-arginine reversed to some extent the deleter
ious effect of L-NNA, although when administered alone it had no apparent e
ffect on the ultrastructure of pancreatic acinar cells compared with untrea
ted animals. The obtained results indicate that the NO synthase inhibitor e
nhances the ultrastructural degenerative alterations in the pancreatic acin
ar cells in the course of caerulein-induced acute pancreatitis and confirm
the protective role of endogenous nitric oxide in this disease.